Delivery Order SPE2DB20D3104-SPE2DB23FV8H6
- Not listed
- This federal contract award is for the delivery of Prevnar 13 syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency. The $3,813.82 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 27, 2021, with a completion date of October 28, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,548.24 firm-fixed-price delivery order is for the supply of PREVNAR 13 syringes (0.5 mL) and has a completion date of May 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award is for the delivery of PREVNAR 13 SYRINGE 0.5ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $83,429.20 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 26, 2022, with a completion date of January 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $9,883.93 for the procurement of PREVNAR 13 syringes from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen brand. The company holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREVNAR 13 syringes. The $7,624.06 firm fixed-price delivery order has an ultimate completion date of April 6, 2023. The award is not set-aside for any specific business type, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is for the supply of PREVNAR 13 syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $16,161.88, is a part of an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a $18,424.84 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of PREVNAR 13 syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PREVNAR 13 syringes. The $2,295.75 firm fixed-price delivery order has an ultimate completion date of August 12, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award is for the delivery of Prevnar 13 syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $18,639.80. The contract has an ultimate completion date of February 10, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and supplies a wide range of medical products to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Prevnar 13 syringes. The delivery order, valued at $56,023.40, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8H6Delivery Order
This federal contract award is for the delivery of PREVNAR 13 syringes to the Defense Logistics Agency (DLA). The $26,582.71 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 8, 2023. The contract has an ultimate completion date of August 9, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 8/8/23 |